Comer: The FDA Has Failed to Prioritize Safety and Incentivize Innovation
April 16, 2024
April 16, 2024
WASHINGTON, April 16 -- Rep. James Comer, R-Kentucky, issued the following news release:
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) today opened a hearing titled "Oversight of the U.S. Food and Drug Administration" to bring transparency to a pattern of issues within the U.S. Food and Drug Administration (FDA) to ensure the FDA is prioritizing safety and effectiveness and incentivizing innovation.
Below are Chairman Comer's rem . . .
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) today opened a hearing titled "Oversight of the U.S. Food and Drug Administration" to bring transparency to a pattern of issues within the U.S. Food and Drug Administration (FDA) to ensure the FDA is prioritizing safety and effectiveness and incentivizing innovation.
Below are Chairman Comer's rem . . .